Brann Mark R 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jan 5, 2006
Insider Transaction Report
Form 4
Brann Mark R
DirectorPresident & CSO
Transactions
- Sale
Common Stock
2006-01-03$10.00/sh−3,500$35,000→ 394,256 total(indirect: By Trust) - Sale
Common Stock
2006-01-04$10.00/sh−3,000$30,000→ 391,256 total(indirect: By Trust) - Sale
Common Stock
2006-01-05$10.00/sh−7,500$75,000→ 383,756 total(indirect: By Trust)
Holdings
- 52,593
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to an existing sales plan established under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.